TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06387641

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Life review
Description: Life review is a process that involves a thorough examination and reflection on one's past experiences, memories, and life events. This process often involves the identification and examination of significant themes, patterns, and lessons learned throughout one's lifespan. Through life review, individuals can gain a deeper understanding of their own identity, values, and beliefs, and how these have shaped their present circumstances and future outlooks. It can serve as a tool for personal growth, self-discovery, and the promotion of a sense of meaning and purpose in life.
Study: NCT05832866

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemonitored Home based Isometric Cntraction strengthening exercises using Thera band
Description: Patients did isometric contraction exercises using thera band at home, they were monitored by telephone three times in a week for 8 weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemonitored Home based Isometric Cntraction strengthening exercises using Thera band
Description: Patients did isometric contraction exercises using thera band at home, they were monitored by telephone three times in a week for 8 weeks
Study: NCT06387641

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Routine community health services
Description: Routine community health services refer to a comprehensive health care service system that is government-led, community-participated, and guided by superior health institutions. It focuses on grass-roots health institutions and is staffed with general practitioners as the backbone. By rationally utilizing community resources, it provides a series of comprehensive health care services to community residents. These services center on human health, target families as the unit, cover the entire community, and aim to meet the basic health service needs of community residents.~Specifically, routine community health services include the following aspects: Health Education, Prevention and Control, Health Care Services and so on.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Routine community health services
Description: Routine community health services refer to a comprehensive health care service system that is government-led, community-participated, and guided by superior health institutions. It focuses on grass-roots health institutions and is staffed with general practitioners as the backbone. By rationally utilizing community resources, it provides a series of comprehensive health care services to community residents. These services center on human health, target families as the unit, cover the entire community, and aim to meet the basic health service needs of community residents.~Specifically, routine community health services include the following aspects: Health Education, Prevention and Control, Health Care Services and so on.
Study: NCT06184958

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine group
Description: Group A: Lidocaine group( 25 patients) will receive 5 mg/Kg lidocaine in 100 ml normal saline given in 40 minutes with 20 minutes follow up to obverse any delayed complication. This procedure will be repeated weekly for 3 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine group
Description: Group B:Ketamine group(25 patients) will receive 0.5 mg/Kg ketamine sulphate in 100 ml normal saline given in 40 minutes with 20 minutes follow up to obverse any delayed complication. This procedure will be repeated weekly for 3 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo group
Description: Group C:placebo group (25 patients) will receive placebo 100 ml normal saline given in 40 minutes with 20 minutes follow up to obverse any delayed complication. This procedure will be repeated weekly for 3 weeks
Study: NCT05179499

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norepinephrine
Description: Norepinepherine should be prepared and delivered at a concentration of 16 micrograms/ml

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Balanced Crystalloid
Description: IV fluids administered as per standard care
Study: NCT06325319

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community engagement using M-MAMA Champions to improve awareness on obstetric danger signs, bith preparedness and complication readiness among pregnant women
Description: Community engagement using M-MAMA Champions to improve awareness of obstetric danger signs, birth preparedness, and complication readiness among pregnant women. The empowered M-MAMA Champions will deliver the intervention to pregnant women in their communities. A total of three (3) sessions will be held, whereby each will take two (2) hours. The sensitization will take place at one of the study participant's residential area, where women will gather up and be sensitized on the subject by the M-MAMA Champion as a facilitator using a well-prepared brochure (package).
Study: NCT04349033

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Disclosure and Brain Education
Description: Patients are interviewed about a number of aspects of their lives (stress, other illnesses, personality, adverse childhood experiences), and these are explored as part of education of the brain's role in their pain.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Emotional Disclosure Only
Description: Patients are interviewed about a number of aspects of their lives, but without brain education

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Pain Information Control
Description: Patients are interviewed about their pain history and other basic, non-disclosure information about their health.
Study: NCT06081192

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Implant placement surgery
Description: Placement of six mini implants in the edentulous maxilla using a partially-guided protocol
Study: NCT06546488

Intervention type: BEHAVIORAL
Intervention: Assessments
Description: A standardized assessment battery will be administered. It will consist of cognitive, functional and motor assessments.
Study: NCT05644093

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPL026 IV
Description: IV dosing

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPL026 IM
Description: IM dosing

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPL026 IM
Description: IM dosing
Study: NCT06499883

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pocket Ark
Description: Pocket Ark (PA) is a mobile e-learning and assessment platform for use by flood remediation workers in the field. The purpose of this mobile application is to provide workers with real-time data to assist with making safe decisions during the planning phase in the flooded zone and provide a communications platform to improve logistics between operational bases and workers during and after the deployment to the flooded zone. Pocket Ark incorporates an action planner, scenario-based PPE training content, assessments (both knowledge and health-risk), personal security protection, and resource location features for workers involved in disaster rescue and recovery. Individual construction worker's readiness to be safely deployed to flooded and post-flood environments will be assessed.
Study: NCT04882839

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: psychotherapy assisted psilocybin
Description: psychotherapy for patients while under the influence of psilocybin
Study: NCT04478409

Intervention type: BIOLOGICAL
Intervention: one additional blood sample during a planned blood test
Description: The study does not change the usual course of care. Only an additional blood sample (4 ml for children under 12 and 10 ml for children 12 and over and adults) during a planned blood test is specific to research (no risk added). The benefit / risk balance therefore remains unchanged with regard to the usual care of patients.
Study: NCT06360614

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand massage application
Description: 2 sessions of hand massage every day, 2 days a week (Monday and Friday) for 4 weeks

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: routine monitoring and nursing care
Description: Routine monitoring and nursing care for 4 weeks
Study: NCT06526156

Intervention type: DRUG
Intervention: Bupivacaine injection
Description: A 3 mL hypobaric (0.33%) solution of bupivacaine, prepared by mixing 2 mL of isobaric (0.5%) bupivacaine with 1 mL of sterile water. Dural puncture will be performed using a 25 or 27G (gauge) spinal needle at the L5-S1 intervertebral space, and the 3 mL of 0.33% bupivacaine will be injected into the intrathecal space.
Study: NCT05042180

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Cognitive Behavioral Therapy (CRAVR)
Description: Participants in the intervention group will scheduled for 14 treatment sessions based on manualized cognitive behavioral therapy assisted with alcohol-related high risk situations in virtual reality. VR-assisted gradual exposure therapy is integrated as a part of CBT. I.e. VR scenes are used in CBT to induce craving for coping strategy skill training and cognitive analysis.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT
Description: The active comparator receives 14 conventional cognitive behavioral therapy sessions with
Study: NCT05805644

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robot mediated upper limb therapy
Description: The OR is classified as a Class A device with the Health Sciences Authority. The OR is capable of delivering RMIT as well as RMTT. It can provide zero, partial or full assistance to the patient to complete the movement or task. Its teach-and-follow mode allows a movement to be performed by the therapist, with the device then replaying the movement at either zero, partial or full assistance for the patient.~Impairment oriented training will focus on the following movements:~1. Diagonal movement~2. Shoulder abduction~3. Shoulder adduction~4. Shoulder flexion~5. Shoulder extension~6. Elbow flexion~7. Elbow extension~Task-specific training will focus on the following activities:~1. Picking up a cup/glass by the side and drink~2. Brushing hair~3. Cleaning unaffected upper limb (hand to arm)~4. Wiping table~5. Wiping wall~6. Sliding card on table to a designated location~7. Clipping a clothe peg

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robot mediated upper limb therapy
Description: The OR is classified as a Class A device with the Health Sciences Authority. The OR is capable of delivering RMIT as well as RMTT. It can provide zero, partial or full assistance to the patient to complete the movement or task. Its teach-and-follow mode allows a movement to be performed by the therapist, with the device then replaying the movement at either zero, partial or full assistance for the patient.~Impairment oriented training will focus on the following movements:~1. Diagonal movement~2. Shoulder abduction~3. Shoulder adduction~4. Shoulder flexion~5. Shoulder extension~6. Elbow flexion~7. Elbow extension~Task-specific training will focus on the following activities:~1. Picking up a cup/glass by the side and drink~2. Brushing hair~3. Cleaning unaffected upper limb (hand to arm)~4. Wiping table~5. Wiping wall~6. Sliding card on table to a designated location~7. Clipping a clothe peg
Study: NCT05549557

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMM40H
Description: IMM40H is a monoclonal antibody with a molecular generated from ImmuneOnco's antibody platform. IMM40H targets CD70 (a tumor cell marker).
Study: NCT05054543

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Uproleselan
Description: A rationally designed E-selectin antagonist used to inhibit binding of cells to E-selectin
Study: NCT06490029

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry
Study: NCT05054543

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% Sodium Chloride
Study: NCT06490029

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry
Study: NCT05771389

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: serum raftlin-1 protein levels
Description: Lipid raft linker 1 (Raftlin-1) is a protein which enables double-stranded RNA binding activity. It is involved in T cell receptor signaling pathway; membrane raft assembly; and positive regulation of growth rate. It acts upstream of or within dsRNA transport; response to exogenous dsRNA; and toll-like receptor signaling pathway. Located in endosome; membrane raft; and plasma membrane.

Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: serum raftlin-1 protein levels
Description: Lipid raft linker 1 (Raftlin-1) is a protein which enables double-stranded RNA binding activity. It is involved in T cell receptor signaling pathway; membrane raft assembly; and positive regulation of growth rate. It acts upstream of or within dsRNA transport; response to exogenous dsRNA; and toll-like receptor signaling pathway. Located in endosome; membrane raft; and plasma membrane.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: serum raftlin-1 protein levels
Description: Lipid raft linker 1 (Raftlin-1) is a protein which enables double-stranded RNA binding activity. It is involved in T cell receptor signaling pathway; membrane raft assembly; and positive regulation of growth rate. It acts upstream of or within dsRNA transport; response to exogenous dsRNA; and toll-like receptor signaling pathway. Located in endosome; membrane raft; and plasma membrane.
Study: NCT06490029

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Auditory, vestibular and electrophysiological investigations
Description: otoacoustic emissions, electrocochleography, vocal audiometry in noise and high-frequency tonal audiometry, impedancemetry

Intervention type: DIAGNOSTIC_TEST
Intervention: Biologic investigations; seric proteins
Description: seric proteins

Intervention type: DIAGNOSTIC_TEST
Intervention: Biologic investigations; seric proteins
Description: seric proteins

Intervention type: DIAGNOSTIC_TEST
Intervention: Biologic investigations; seric proteins
Description: seric proteins

Intervention type: DIAGNOSTIC_TEST
Intervention: Biologic investigations; seric proteins
Description: seric proteins

Intervention type: DIAGNOSTIC_TEST
Intervention: Biologic investigations; seric proteins
Description: seric proteins

Intervention type: DIAGNOSTIC_TEST
Intervention: Biologic investigations; seric proteins
Description: seric proteins

Intervention type: DIAGNOSTIC_TEST
Intervention: Biologic investigations; seric proteins
Description: seric proteins
Study: NCT05700981

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: colon capsule endoscopy
Description: Patient allocated for the intervention arm will have a CCE using the PillCam Colon 2 (Medtronic, Minneapolis, Minnesota, USA). Upon inclusion and allocation to the intervention arm patients are contacted by a dedicated CCE nurse. The course of the CCE procedure and preparations are explained thoroughly. In case of additional questions patients can contact the nurses by telephone during office hours (Monday-Friday, 8am-3pm). Before the CCE participants will have to undergo a bowel preparation procedure. The bowel preparation kit will be distributed by mail and is to be completed at home, beginning 72 hours before the CCE. The kit contains polyethylene glycol (PEG) sachets (Movicol, Norgine Danmark A/S, Herlev, Denmark), PEG solutions (MoviPrep, Norgine Danmark A/S, Herlev Denmark) and instructions on how to properly perform the preparation procedures.
Study: NCT05916729

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miconazole
Description: Protocol for active control groups includes use of Miconazole Oral gel for 14 days with frequency of four time per day.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Miconazole
Description: Protocol for active control groups includes use of Miconazole Oral gel for 14 days with frequency of four time per day.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Miconazole
Description: Protocol for active control groups includes use of Miconazole Oral gel for 14 days with frequency of four time per day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miconazole
Description: Protocol for active control groups includes use of Miconazole Oral gel for 14 days with frequency of four time per day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miconazole
Description: Protocol for active control groups includes use of Miconazole Oral gel for 14 days with frequency of four time per day.
Study: NCT05499624

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MicroTrend System
Description: The hands-free device measures oral mucosal carbon dioxide pressure (POMCO2) and functions outside of the body and does not require a surgical procedure or any significant deviation from standard practice to operate.
Study: NCT04833959

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 89Zr-panitumumab
Description: Imaging Agent
Study: NCT03191370

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simple distraction technique
Description: Asking the patient to count backwards from 30 to1 in even numbers whilst the procedure is being performed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simple distraction technique
Description: Asking the patient to count backwards from 30 to1 in even numbers whilst the procedure is being performed.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Local Anesthetics,Topical
Description: Anesthetic spray

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Local Anesthetics,Topical
Description: Anesthetic spray
Study: NCT05301036

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diadem prototype
Description: Diadem prototype device delivers personalized low-intensity transcranial focused ultrasound stimulation